BEAM logo

Beam Therapeutics Inc. (BEAM) EBITDA

Annual EBITDA:

-$393.64M-$237.17M(-151.57%)
December 31, 2024

Summary

  • As of today, BEAM annual EBITDA is -$393.64 million, with the most recent change of -$237.17 million (-151.57%) on December 31, 2024.
  • During the last 3 years, BEAM annual EBITDA has fallen by -$17.62 million (-4.69%).
  • BEAM annual EBITDA is now -4902.45% below its all-time high of -$7.87 million, reached on December 31, 2017.

Performance

BEAM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBEAMincome statement metrics

Quarterly EBITDA:

-$114.61M-$855.00K(-0.75%)
June 30, 2025

Summary

  • As of today, BEAM quarterly EBITDA is -$114.61 million, with the most recent change of -$855.00 thousand (-0.75%) on June 30, 2025.
  • Over the past year, BEAM quarterly EBITDA has dropped by -$15.29 million (-15.40%).
  • BEAM quarterly EBITDA is now -177.58% below its all-time high of $147.74 million, reached on December 31, 2023.

Performance

BEAM Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBEAMincome statement metrics

TTM EBITDA:

-$414.33M-$15.29M(-3.83%)
June 30, 2025

Summary

  • As of today, BEAM TTM EBITDA is -$414.33 million, with the most recent change of -$15.29 million (-3.83%) on June 30, 2025.
  • Over the past year, BEAM TTM EBITDA has dropped by -$260.96 million (-170.16%).
  • BEAM TTM EBITDA is now -484.03% below its all-time high of -$70.94 million, reached on September 30, 2019.

Performance

BEAM TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBEAMincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

BEAM EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-151.6%-15.4%-170.2%
3Y3 Years-4.7%-45.9%-47.9%
5Y5 Years-464.4%-355.9%-263.9%

BEAM EBITDA Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-151.6%at low-177.6%at low-181.9%at low
5Y5-Year-464.4%at low-177.6%+42.4%-263.9%at low
All-TimeAll-Time-4902.4%at low-177.6%+42.4%-484.0%at low

BEAM EBITDA History

DateAnnualQuarterlyTTM
Jun 2025
-
-$114.61M(-0.8%)
-$414.33M(-3.8%)
Mar 2025
-
-$113.76M(-33.9%)
-$399.03M(-3.9%)
Dec 2024
-$393.64M(-151.6%)
-$84.93M(+15.9%)
-$383.98M(-153.8%)
Sep 2024
-
-$101.03M(-1.7%)
-$151.31M(+1.3%)
Jun 2024
-
-$99.32M(-0.6%)
-$153.36M(-1.3%)
Mar 2024
-
-$98.70M(-166.8%)
-$151.37M(-3.0%)
Dec 2023
-$156.47M(+50.5%)
$147.74M(+243.3%)
-$146.95M(+60.4%)
Sep 2023
-
-$103.08M(-5.9%)
-$371.30M(-4.3%)
Jun 2023
-
-$97.33M(-3.2%)
-$356.05M(-5.6%)
Mar 2023
-
-$94.28M(-23.1%)
-$337.27M(-6.8%)
Dec 2022
-$315.90M(+16.0%)
-$76.61M(+12.8%)
-$315.90M(-5.3%)
Sep 2022
-
-$87.83M(-11.8%)
-$300.14M(-7.1%)
Jun 2022
-
-$78.55M(-7.7%)
-$280.19M(-8.2%)
Mar 2022
-
-$72.91M(-19.8%)
-$258.95M(+32.7%)
DateAnnualQuarterlyTTM
Dec 2021
-$376.02M(-205.0%)
-$60.85M(+10.4%)
-$385.01M(-5.9%)
Sep 2021
-
-$67.88M(-18.5%)
-$363.69M(-9.6%)
Jun 2021
-
-$57.30M(+71.2%)
-$331.91M(-10.7%)
Mar 2021
-
-$198.97M(-403.4%)
-$299.75M(-134.1%)
Dec 2020
-$123.29M(-76.8%)
-$39.53M(-9.5%)
-$128.03M(-12.4%)
Sep 2020
-
-$36.10M(-43.6%)
-$113.87M(-20.0%)
Jun 2020
-
-$25.14M(+7.8%)
-$94.88M(-9.6%)
Mar 2020
-
-$27.25M(-7.4%)
-$86.53M(-20.8%)
Dec 2019
-$69.75M(-54.7%)
-$25.37M(-48.2%)
-$71.65M(-1.0%)
Sep 2019
-
-$17.12M(-1.9%)
-$70.94M(+43.6%)
Jun 2019
-
-$16.79M(-35.7%)
-$125.82M(-15.4%)
Mar 2019
-
-$12.37M(+49.8%)
-$109.02M(-12.8%)
Dec 2018
-$45.09M(-473.0%)
-$24.66M(+65.7%)
-$96.65M(-34.3%)
Sep 2018
-
-$71.99M
-$71.99M
Dec 2017
-$7.87M
-
-

FAQ

  • What is Beam Therapeutics Inc. annual EBITDA?
  • What is the all-time high annual EBITDA for Beam Therapeutics Inc.?
  • What is Beam Therapeutics Inc. annual EBITDA year-on-year change?
  • What is Beam Therapeutics Inc. quarterly EBITDA?
  • What is the all-time high quarterly EBITDA for Beam Therapeutics Inc.?
  • What is Beam Therapeutics Inc. quarterly EBITDA year-on-year change?
  • What is Beam Therapeutics Inc. TTM EBITDA?
  • What is the all-time high TTM EBITDA for Beam Therapeutics Inc.?
  • What is Beam Therapeutics Inc. TTM EBITDA year-on-year change?

What is Beam Therapeutics Inc. annual EBITDA?

The current annual EBITDA of BEAM is -$393.64M

What is the all-time high annual EBITDA for Beam Therapeutics Inc.?

Beam Therapeutics Inc. all-time high annual EBITDA is -$7.87M

What is Beam Therapeutics Inc. annual EBITDA year-on-year change?

Over the past year, BEAM annual EBITDA has changed by -$237.17M (-151.57%)

What is Beam Therapeutics Inc. quarterly EBITDA?

The current quarterly EBITDA of BEAM is -$114.61M

What is the all-time high quarterly EBITDA for Beam Therapeutics Inc.?

Beam Therapeutics Inc. all-time high quarterly EBITDA is $147.74M

What is Beam Therapeutics Inc. quarterly EBITDA year-on-year change?

Over the past year, BEAM quarterly EBITDA has changed by -$15.29M (-15.40%)

What is Beam Therapeutics Inc. TTM EBITDA?

The current TTM EBITDA of BEAM is -$414.33M

What is the all-time high TTM EBITDA for Beam Therapeutics Inc.?

Beam Therapeutics Inc. all-time high TTM EBITDA is -$70.94M

What is Beam Therapeutics Inc. TTM EBITDA year-on-year change?

Over the past year, BEAM TTM EBITDA has changed by -$260.96M (-170.16%)
On this page